Suppr超能文献

肥胖合并肝硬化患者行代谢和减重手术的安全性:系统评价和荟萃分析。

Safety of metabolic and bariatric surgery in obese patients with liver cirrhosis: a systematic review and meta-analysis.

机构信息

Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, India.

Department of Emergency Medicine, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Surg Obes Relat Dis. 2021 Mar;17(3):525-537. doi: 10.1016/j.soard.2020.11.004. Epub 2020 Nov 13.

Abstract

BACKGROUND

With the pandemic of obesity and the growing experience in metabolic and bariatric surgery (MBS), the number of patients with obesity and liver cirrhosis undergoing MBS is increasing.

OBJECTIVE

To analyze the morbidity and mortality following MBS in patients with obesity and liver cirrhosis.

SETTING

Systematic review and meta-analysis.

METHODS

The published literature was systematically reviewed, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, for studies reporting outcomes of MBS among patients with liver cirrhosis. The predetermined endpoints were the overall complication after MBS, intraoperative complications, liver-related complications after MBS, all-cause 90-day mortality after MBS, and liver-related mortality post-MBS. The pooled weighted proportions for each of the endpoints was calculated using random effect meta-analysis.

RESULTS

A total of 18 studies, including 471 patients with obesity and liver cirrhosis undergoing MBS, qualified for the final quantitative analysis. The mean age and mean body mass index (BMI) of the pooled patient cohort were 50.2 years and 47.2 kg/m. The pooled weighted proportions of the overall post-MBS complications, intraoperative complications, liver-related complications, overall 90-day mortality, and liver failure related mortality post MBS were 22.14% (CI: 15.43%-29.55%), .08% (CI: 0%-1.02%), 4.62% (CI: 1.27%-9.30%), 0% (CI: 0%-.44%), .08% (CI: 0%-1.03%), respectively. Significantly lower postoperative complications were noted with sleeve gastrectomy (10.08% [95%CI: 5.14%-16%]) compared with Roux-en-Y gastric bypass (31.53% [95%CI: 18.62%-45.68%]; (P = .02).

CONCLUSION

We found an overall low postoperative surgical and liver-related mortality post MBS among patients with obesity and liver cirrhosis. The overall postoperative complications and liver-related complications were higher among patients with liver cirrhosis than in noncirrhotic patients. Sleeve gastrectomy showed lower postoperative complications compared with Roux-en-Y gastric bypass.

摘要

背景

随着肥胖症的流行和代谢与减重手术(MBS)经验的不断增加,越来越多的肥胖症合并肝硬化患者接受了 MBS。

目的

分析肥胖症合并肝硬化患者接受 MBS 后的发病率和死亡率。

设置

系统回顾和荟萃分析。

方法

按照系统评价和荟萃分析的首选报告项目(PRISMA)指南,对报道肝硬化患者 MBS 结局的文献进行了系统回顾。预定的终点是 MBS 后的总体并发症、术中并发症、MBS 后与肝脏相关的并发症、MBS 后 90 天全因死亡率和 MBS 后与肝脏相关的死亡率。使用随机效应荟萃分析计算每个终点的加权合并比例。

结果

共有 18 项研究,包括 471 例肥胖症合并肝硬化患者接受了 MBS,符合最终的定量分析标准。汇总患者队列的平均年龄和平均体重指数(BMI)分别为 50.2 岁和 47.2kg/m。MBS 后总体并发症、术中并发症、与肝脏相关的并发症、MBS 后 90 天全因死亡率和 MBS 后与肝脏相关的死亡率的加权合并比例分别为 22.14%(CI:15.43%-29.55%)、0.08%(CI:0%-1.02%)、4.62%(CI:1.27%-9.30%)、0%(CI:0%-.44%)和 0.08%(CI:0%-1.03%)。与 Roux-en-Y 胃旁路术(31.53%[CI:18.62%-45.68%])相比,袖状胃切除术(10.08%[CI:5.14%-16%])术后并发症明显减少(P =.02)。

结论

我们发现肥胖症合并肝硬化患者 MBS 后整体手术和与肝脏相关的死亡率较低。与非肝硬化患者相比,肝硬化患者的总体术后并发症和与肝脏相关的并发症更高。与 Roux-en-Y 胃旁路术相比,袖状胃切除术的术后并发症更低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验